International corporate newswires have yet to pick up the news that Novartis put out yesterday (August 24).
In an update addressed to its investors Novartis admitted that it has failed to produce a vaccine for COVID-19, IntelCaster has learned through the Bonnier press group.
The fact that they weren’t able to produce a COVID-19 vaccine is, in itself, not surprising though. For decades big pharma has been producing flu vaccines but none of the vaccines ever reached an efficiency that is higher than 50%. This means that in general half of the people who get the seasonal flu shot are not protected by it against flu viruses. In May of this year, Bill Gates admitted that this year’s flu vaccine is only 45% efficient. Those are odds that even a casino player can beat.
What is surprising, although certainly not to everyone, is that they admit this and that the mainstream media is not even talking about it.
The fact that Novartis has officially stated that they have failed to produce the vaccine also means that they’re aware that there’s no point in even trying to produce such a vaccine in a short period of time – in months instead of in a decade and longer, which is the time it takes to safely and ethically produce a new drug or vaccine.
If Novartis can’t produce a COVID-19 vaccine there’s no reason, whatsoever, to assume that any other pharma company will be able to do so. For this, simply look at the failed flu vaccine, year after year, decade after decade.
In April Novartis’ CEO Vas Narasimhan stated that hydroxychloroquine provides relief from SARS-CoV-2.
Since then, the World Health Organization has been campaigning aggressively against hydroxychloroquine as a COVID-19 treatment. Mainly because the Bill and Melinda Gates Foundation and the Chinese government want to make hundreds of billions of dollars selling worthless, and potentially very dangerous, COVID-19 vaccines.